Since in cell systems, IDN 5390 was unable to overcome Pgp-mediated resistance (Table 1), mechanisms other than a direct cytotoxicity against tumour cells seem to contribute to its antitumour efficacy in vivo. Here, PGP is linked to neoplasm.